Keros Therapeutics Inc (KROS)
17.98
-1.44
(-7.42%)
USD |
NASDAQ |
Dec 17, 16:00
17.87
-0.11
(-0.61%)
After-Hours: 18:00
Keros Therapeutics Total Liabilities (Quarterly): 46.44M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aptevo Therapeutics Inc | 10.73M |
| Corcept Therapeutics Inc | 145.42M |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Scholar Rock Holding Corp | 99.94M |
| Trevi Therapeutics Inc | 9.939M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 579.27M |
| Shareholders Equity (Quarterly) | 532.84M |
| Current Ratio | 19.03 |